• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?

作者信息

Wang Andrew Z

机构信息

Laboratory of Nano- and Translational Medicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, 101 Manning Drive, CB 7512, Chapel Hill, NC 27599-7512, USA.

出版信息

EBioMedicine. 2014 Nov 20;1(2-3):101-2. doi: 10.1016/j.ebiom.2014.11.013. eCollection 2014 Dec.

DOI:10.1016/j.ebiom.2014.11.013
PMID:26137516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4457346/
Abstract
摘要

相似文献

1
Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?小干扰RNA的纳米颗粒制剂：淋巴瘤和白血病的下一代靶向治疗？
EBioMedicine. 2014 Nov 20;1(2-3):101-2. doi: 10.1016/j.ebiom.2014.11.013. eCollection 2014 Dec.
2
Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.受体靶向脂质体-肽纳米复合物用于 siRNA 递药。
Biomaterials. 2011 Sep;32(26):6302-15. doi: 10.1016/j.biomaterials.2011.05.022. Epub 2011 May 31.
3
Characterization and classification of rat leukemias and lymphomas by membrane markers.通过膜标志物对大鼠白血病和淋巴瘤进行特征描述与分类。
Cancer Res. 1981 May;41(5):1938-42.
4
Pax5 expression in non-Hodgkin's lymphomas and acute leukemias.Pax5在非霍奇金淋巴瘤和急性白血病中的表达。
J Korean Med Sci. 2003 Dec;18(6):804-8. doi: 10.3346/jkms.2003.18.6.804.
5
013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.血液系统增殖中013（CD99）阳性与末端脱氧核苷酸转移酶（TdT）阳性相关。
Mod Pathol. 1997 Apr;10(4):277-82.
6
Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.由两阶段聚乙二醇化步骤组成的长循环阳离子纳米颗粒制剂的表征，用于在乳腺癌肿瘤模型中递送 siRNA。
J Pharm Sci. 2013 Jan;102(1):227-36. doi: 10.1002/jps.23351. Epub 2012 Nov 6.
7
[Neoplastic meningosis in immature cell leukemias and malignant lymphomas].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1985;112(4):515-24.
8
Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.递送血管内皮生长因子-C小干扰RNA的碳酸钙纳米颗粒可有效抑制体内胃癌的淋巴管生成和生长。
Cancer Gene Ther. 2008 Mar;15(3):193-202. doi: 10.1038/sj.cgt.7701122. Epub 2008 Jan 18.
9
Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.通过碳酸钙纳米颗粒递送的血管内皮生长因子-C小干扰RNA可有效抑制体内结直肠癌的淋巴管生成和生长。
Cancer Biother Radiopharm. 2009 Apr;24(2):249-59. doi: 10.1089/cbr.2008.0515.
10
Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas.脾脏酪氨酸激酶作为治疗白血病和淋巴瘤的分子靶标。
Expert Rev Anticancer Ther. 2010 Sep;10(9):1407-18. doi: 10.1586/era.10.112.

引用本文的文献

1
Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer.局部化疗方法与先进药物递送策略：卵巢癌腹膜癌治疗的新进展。
Front Oncol. 2023 May 23;13:1125868. doi: 10.3389/fonc.2023.1125868. eCollection 2023.
2
Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin.基于 DJ-1 蛋白 siRNA 介导抑制与低剂量顺铂联合的腹腔内纳米治疗转移性卵巢癌。
Nanomedicine. 2018 Jun;14(4):1395-1405. doi: 10.1016/j.nano.2018.03.005. Epub 2018 Apr 7.

本文引用的文献

1
A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies.一种为B系淋巴恶性肿瘤的RNA干扰疗法而合理设计的纳米颗粒。
EBioMedicine. 2014 Dec;1(2-3):141-155. doi: 10.1016/j.ebiom.2014.10.013.
2
Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinician.进入慢性淋巴细胞白血病的靶向治疗时代：对临床执业医师的影响
J Clin Oncol. 2014 Sep 20;32(27):3039-47. doi: 10.1200/JCO.2014.55.8262.
3
Delivery materials for siRNA therapeutics.siRNA 治疗药物的递送材料。
Nat Mater. 2013 Nov;12(11):967-77. doi: 10.1038/nmat3765.
4
Cyclin D as a therapeutic target in cancer.细胞周期蛋白 D 作为癌症治疗靶点。
Nat Rev Cancer. 2011 Jul 7;11(8):558-72. doi: 10.1038/nrc3090.
5
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.多中心独立评估伊马替尼治疗慢性髓性白血病患者的结局。
J Natl Cancer Inst. 2011 Apr 6;103(7):553-61. doi: 10.1093/jnci/djr060. Epub 2011 Mar 21.
6
Targeted therapy in lymphoma.淋巴瘤的靶向治疗。
J Hematol Oncol. 2010 Nov 23;3:45. doi: 10.1186/1756-8722-3-45.
7
Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics.费城染色体阳性白血病：从基本机制到分子治疗
Ann Intern Med. 2003 May 20;138(10):819-30. doi: 10.7326/0003-4819-138-10-200305200-00010.
8
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.一种BCR-ABL酪氨酸激酶特异性抑制剂在慢性髓性白血病中的疗效与安全性
N Engl J Med. 2001 Apr 5;344(14):1031-7. doi: 10.1056/NEJM200104053441401.
9
Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization.通过荧光原位杂交检测套细胞淋巴瘤中的t(11;14)(q13;q32)易位
Am J Pathol. 1999 May;154(5):1449-52. doi: 10.1016/S0002-9440(10)65399-0.